Materials & Resources » Chemicals | MagForce AG

MagForce AG | Mutual Funds

Mutual Funds that own MagForce AG

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
660,568
2.5%
-11,586
1.72%
06/30/2018
M&G Investment Funds (1) OEIC - European Smaller Companies Fd.
610,461
2.31%
0
2.02%
03/29/2018
Baring German Growth Trust
360,000
1.37%
0
0.32%
10/31/2017
Investors International Small Cap Class
291,954
1.11%
59,318
0.47%
03/31/2018
M&G International Specialist Equity Fund
285,000
1.08%
0
0.47%
03/29/2018
UBS (D) Equity Fund - Small Caps Germany
225,000
0.85%
0
0.65%
01/31/2018
219,778
0.83%
219,778
1.62%
04/30/2018
Pearlfisher Fund -B-
150,000
0.56%
0
1.75%
06/30/2017
Schroder ISF - European Smaller Companies
150,000
0.56%
0
0.28%
12/29/2017
CF Ruffer Investment Funds - Equity & General Fund
130,500
0.5%
0
0.68%
04/30/2018

About MagForce

View Profile
Address
Max-Planck-Strasse 3
Berlin Berlin 12489
Germany
Employees -
Website http://www.magforce.de
Updated 07/08/2019
MagForce AG is a medical device company, which engages in the provision of nanotechnology solutions. Its products include NanoTherm Therapy, NanoTherm, NanoPlan, and NanoActivator. The company was founded in 1997 and is headquartered in Berlin, Germany.